Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Glioblastoma 1Brain Neoplasms 1Advanced Breast Cancer 1

Interventions

Fulvestrant 3trastuzumab deruxtecan 2Letrozole 2Injections 2AZD9833 2toripalimab 1ribociclib 1palbociclib 1exemestane 1abemaciclib 1Ritonavir 1Paclitaxel 1Lead 1Itraconazole 1Goserelin 1Anastrozole 1AZD5305 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Lead × 30 days × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡